Elyashiv O - Search Results

1

ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.

Elyashiv O, Ledermann J, Parmar G, Farrelly L, Counsell N, Feeney A, El-Khouly F, Macdonald I, Neto A, Arthur-Darkwa E, Burnett E, Jayson GC, Mileshkin L, Gourley C, Nicum S. Elyashiv O, et al. Int J Gynecol Cancer. 2021 Jan;31(1):134-138. doi: 10.1136/ijgc-2020-002073. Epub 2020 Oct 23. Int J Gynecol Cancer. 2021. PMID: 33097567

2

Frontline Maintenance Treatment for Ovarian Cancer.

Elyashiv O, Wong YNS, Ledermann JA. Elyashiv O, et al. Curr Oncol Rep. 2021 Jun 14;23(8):97. doi: 10.1007/s11912-021-01088-w. Curr Oncol Rep. 2021. PMID: 34125335 Free PMC article. Review.

3

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors.

Miller RE, Elyashiv O, El-Shakankery KH, Ledermann JA. Miller RE, et al. Among authors: elyashiv o. Onco Targets Ther. 2022 Oct 4;15:1105-1117. doi: 10.2147/OTT.S272199. eCollection 2022. Onco Targets Ther. 2022. PMID: 36217436 Free PMC article. Review.

4

Retroperitoneal lymph node recurrence of epithelial ovarian cancer: Prognostic factors and treatment outcome.

Levy T, Migdan Z, Aleohin N, Ben-Shem, Peled O, Tal O, Elyashiv O. Levy T, et al. Among authors: elyashiv o. Gynecol Oncol. 2020 May;157(2):392-397. doi: 10.1016/j.ygyno.2020.02.022. Epub 2020 Mar 6. Gynecol Oncol. 2020. PMID: 32151375

5

Anatomic Asymmetry in Sentinel Lymph Node Detection in Endometrial Cancer.

Tal O, Grinstein E, Goshen E, Oksman Y, Lorberboym M, Elyashiv O, Ben Shem E, Peled O, Levy T. Tal O, et al. Among authors: elyashiv o. J Minim Invasive Gynecol. 2021 Aug;28(8):1531-1535. doi: 10.1016/j.jmig.2020.12.029. Epub 2020 Dec 26. J Minim Invasive Gynecol. 2021. PMID: 33373726

6

The Association of an Elevated Thrombocyte Count with Clinicopathological Prognostic Factors and Survival in Patients with Uterine Carcinosarcoma.

Menczer J, Elyashiv O, Ben-Shem E, Peled O, Levy T. Menczer J, et al. Among authors: elyashiv o. Isr Med Assoc J. 2018 Apr;20(4):213-216. Isr Med Assoc J. 2018. PMID: 29629727 Free article.

7

Age Disparities in End of Life Symptom Management Among Patients with Epithelial Ovarian Cancer.

Tal O, Ben Shem E, Peled O, Elyashiv O, Levy T. Tal O, et al. Among authors: elyashiv o. J Palliat Care. 2023 Apr;38(2):184-191. doi: 10.1177/08258597221083418. Epub 2022 Feb 28. J Palliat Care. 2023. PMID: 35225068

8

Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy?

Elyashiv O, Sagiv R, Kerner R, Keidar R, Menczer J, Levy T. Elyashiv O, et al. J Minim Invasive Gynecol. 2017 Nov-Dec;24(7):1200-1203. doi: 10.1016/j.jmig.2017.08.002. Epub 2017 Aug 9. J Minim Invasive Gynecol. 2017. PMID: 28802955

9

Is There a Difference in the Outcome of Mid-Urethral Sling Operations Performed by Urogynecologists Compared with Supervised Residents?

Elyashiv O, Zussman NM, Ben-Zvi M, Bar J, Sagiv R, Condrea A, Ginath S. Elyashiv O, et al. J Minim Invasive Gynecol. 2018 Jul-Aug;25(5):878-883. doi: 10.1016/j.jmig.2018.01.008. Epub 2018 Jan 12. J Minim Invasive Gynecol. 2018. PMID: 29339299

10

Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia.

Kovo M, Schreiber L, Elyashiv O, Ben-Haroush A, Abraham G, Bar J. Kovo M, et al. Among authors: elyashiv o. Reprod Sci. 2015 Mar;22(3):316-21. doi: 10.1177/1933719114542024. Epub 2014 Jul 6. Reprod Sci. 2015. PMID: 25001023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters